Mount Pleasant, SC, United States of America

Liu Xiang

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Musc Foundation for Research Development. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Liu Xiang. Retrieved from https://idiyas.com/inventor/liu-xiang-rc12s4ge

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 



Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Liu Xiang: Innovator in Pharmaceutical Research

Introduction

Liu Xiang is a notable inventor based in Mount Pleasant, SC (US). He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target specific biological activities.

Latest Patents

Liu Xiang holds a patent for "Lysosomotropic inhibitors of acid ceramidase." This patent describes compounds that inhibit acid ceramidase and ceramidase-related activity. The disclosed compounds are useful in treating diseases associated with undesirable ceramidase or sphingosine kinase activity, including cancer, cancer metastasis, atherosclerosis, stenosis, inflammation, asthma, and atopic dermatitis. He has 1 patent to his name.

Career Highlights

Liu Xiang is affiliated with the MUSC Foundation for Research Development, where he continues to advance his research and innovation in the pharmaceutical sector. His work focuses on developing new therapeutic strategies to combat various diseases.

Collaborations

Some of his notable coworkers include Alicja Bielawska and Yusuf A Hannun, who contribute to the collaborative efforts in research and development within the foundation.

Conclusion

Liu Xiang's innovative work in pharmaceutical research exemplifies the impact of targeted therapies in modern medicine. His contributions are paving the way for new treatments that address critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…